Changes in Depression and Anxiety in a Randomized, Double-blind, Placebo-controlled Study of Galcanezumab in Adults with Treatment-resistant Migraine: Results from the CONQUER Study

被引:0
|
作者
Maizels, Morris [1 ]
Buse, Dawn C. [2 ]
Jedynak, Jakub [3 ]
Hand, Austin L. [4 ]
Ford, Janet [3 ]
Detke, Holland [3 ]
机构
[1] Providence St Joseph Hlth, Renton, WA USA
[2] Yeshiva Univ, Albert Einstein Coll Med, New York, NY 10033 USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] IQVIA, Durham, NC USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1383
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Assesment of anxiety and depression in a randomized, double-blind, placebo-controlled study of galcanezumab in adults with treatment-resistant migraine: Results from the conquer study
    Maizels, M.
    Buse, D.
    Jedynak, J. P.
    Hand, A.
    Ford, J. H.
    Detke, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [2] A Randomized, Placebo-Controlled Study of Galcanezumab in Patients with Treatment-Resistant Migraine: Double-Blind Results from the CONQUER Study
    Mulleners, Wim
    Kim, Byung-Kun
    Lainez, Miguel
    Lanteri-Minet, Michel
    Aurora, Sheena
    Nichols, Russell
    Wang, Shufang
    Tockhorn-Heidenreich, Antje
    Detke, Holland
    NEUROLOGY, 2020, 94 (15)
  • [3] A Randomized, Placebo-Controlled Study of Galcanezumab in Patients with Treatment-Resistant Migraine: Double-Blind Results from the CONQUER Study
    Mulleners, Wim M.
    Kim, Byungkun
    Lainez, Miguel J.
    Lanteri-Minet, Michel
    Aurora, Sheena K.
    Nichols, Russell M.
    Wang, Shufang
    Tockhorn-Heidenreich, Antje
    Detke, Holland C.
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 366 - 366
  • [4] Changes in Work Productivity and Interictal Burden: Results from a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Galcanezumab in Adults with Treatment-Resistant Migraine (CONQUER)
    Garcia-Azorin, D.
    Ford, J.
    Buse, D.
    Hand, A.
    Wietecha, L.
    Detke, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 160 - 160
  • [5] Changes in Work Productivity and Interictal Burden: Results from a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Galcanezumab in Adults with Treatment-Resistant Migraine (CONQUER)
    Garcia-Azorin, David
    Ford, Janet
    Buse, Dawn
    Hand, Austin
    Wietecha, Linda
    Detke, Holland
    NEUROLOGY, 2020, 94 (15)
  • [6] A phase 3 placebo-controlled study of galcanezumab in patients with treatment-resistant migraine: Results from the 3-month double-blind treatment phase of the conquer study
    Mulleners, W.
    Kim, B.
    Lainez, M. J.
    Lanteri-Minet, M.
    Aurora, S. K.
    Nichols, R. M.
    Wang, S.
    Tockhorn-Heidenreich, A.
    Detke, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [7] Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER)
    Ambrosini, Anna
    Estemalik, Emad
    Pascual, Julio
    Rettiganti, Mallikarjuna
    Stroud, Chad
    Day, Kathleen
    Ford, Janet
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 645 - 656
  • [8] Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
    Detke, Holland C.
    Goadsby, Peter J.
    Wang, Shufang
    Friedman, Deborah I.
    Selzler, Katherine J.
    Aurora, Sheena K.
    NEUROLOGY, 2018, 91 (24) : E2211 - E2221
  • [9] Efficacy of Galcanezumab in Adults With Treatment Resistant Migraine and Concomitant Pain Disorders: Post-hoc Subpopulation Analyses From the Randomized, Double-Blind, Placebo-Controlled CONQUER Study
    Argoff, C.
    Dong, Y.
    Li, L. Q.
    Barad, M.
    Wright, P.
    HEADACHE, 2020, 60 : 105 - 106
  • [10] Efficacy and Safety of Esketamine Nasal Spray as Monotherapy in Adults With Treatment-Resistant Depression: A Randomized, Double-Blind, Placebo-Controlled Study
    Janik, Adam
    Qiu, Xin
    Lane, Rosanne
    Popova, Vanina
    Drevets, Wayne C.
    Canuso, Carla M.
    Fu, Dong-Jing
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 161 - 162